| For the Year Ended | For the Three-Month Period Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2021 | 2022 | 2021 | 2022 | |||||||||||||
| Revenues | 10,493 | 43,633 | 7,531 | 12,104 | ||||||||||||
| Cost of revenues | 5,730 | 24,943 | 4,350 | 3,784 | ||||||||||||
| Cost of revenues - write-down of inventories and impairment of assets recognized in business combination and technology | 3,641 | 4,639 | 2,869 | 649 | ||||||||||||
| Total cost of revenues | 9,371 | 29,582 | 7,219 | 4,433 | ||||||||||||
| Gross profit | 1,122 | 14,051 | 312 | 7,671 | ||||||||||||
| Research and development expenses, net | 41,686 | 75,763 | 15,099 | 20,993 | ||||||||||||
| Sales and marketing expenses | 22,713 | 38,833 | 7,690 | 9,758 | ||||||||||||
| General and administrative expenses | 19,644 | 30,457 | 6,470 | 9,091 | ||||||||||||
| Impairment losses | 140,290 | 40,523 | 140,290 | 40,523 | ||||||||||||
| Operating loss | (223,211 | ) | (171,525 | ) | (169,237 | ) | (72,694 | ) | ||||||||
| Finance income | 17,909 | 22,965 | 5,326 | 11,105 | ||||||||||||
| Finance expense | 428 | 79,471 | — | 25,305 | ||||||||||||
| Loss before taxes on income | (205,730 | ) | (228,031 | ) | (163,911 | ) | (86,894 | ) | ||||||||
| Taxes benefit (expense) | 4,906 | (264 | ) | 4,258 | (1,006 | ) | ||||||||||
| Loss for the year | (200,824 | ) | (228,295 | ) | (159,653 | ) | (87,900 | ) | ||||||||
| Loss attributable to non-controlling interests | (47 | ) | (872 | ) | (29 | ) | (233 | ) | ||||||||
| Loss attributable to owners | (200,777 | ) | (227,423 | ) | (159,624 | ) | (87,667 | ) | ||||||||
| Loss per share | ||||||||||||||||
| Basic loss per share | (0.81 | ) | (0.88 | ) | (0.62 | ) | (0.34 | ) | ||||||||
| Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss | ||||||||||||||||
| Foreign currency translation differences for foreign operations | (46 | ) | (844 | ) | (46 | ) | 1,507 | |||||||||
| Other comprehensive income items that will not be transferred to profit or loss | ||||||||||||||||
| Remeasurement of net defined benefit liability (IAS 19), net of tax | — | 2,508 | — | (619 | ) | |||||||||||
| Total other comprehensive income (loss) for the year | (46 | ) | 1,664 | (46 | ) | 888 | ||||||||||
| Total comprehensive loss for the year | (200,870 | ) | (226,631 | ) | (159,699 | ) | (87,012 | ) | ||||||||
| Comprehensive loss attributable to non-controlling interests | (69 | ) | (892 | ) | (51 | ) | (157 | ) | ||||||||
| Comprehensive loss attributable to owners of the Company | (200,801 | ) | (225,739 | ) | (159,648 | ) | (86,855 | ) | ||||||||
Consolidated Statements of Changes in Equity
